Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal

Bram L. T. Ramaekers; Rob Riemsma; Florian Tomini; Thea van Asselt; Sohan Deshpande; Steven Duffy; Nigel Armstrong; Johan L. Severens; Jos Kleijnen; Manuela A. Joore

doi:10.1007/s40273-016-0445-5

Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal

Bram L. T. Ramaekers^*, Rob Riemsma, Florian Tomini, Thea van Asselt, Sohan Deshpande, Steven Duffy, Nigel Armstrong, Johan L. Severens, Jos Kleijnen, Manuela A. Joore

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	191-202
Number of pages	12
Journal	Pharmacoeconomics
Volume	35
Issue number	2
DOIs	https://doi.org/10.1007/s40273-016-0445-5
Publication status	Published - Feb 2017

Keywords

PLACEBO-CONTROLLED PHASE-3
SURVIVAL ANALYSIS
DOUBLE-BLIND

Access to Document

10.1007/s40273-016-0445-5

Cite this

Ramaekers, B. L. T., Riemsma, R., Tomini, F., van Asselt, T., Deshpande, S., Duffy, S., Armstrong, N., Severens, J. L., Kleijnen, J., & Joore, M. A. (2017). Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal. Pharmacoeconomics, 35(2), 191-202. https://doi.org/10.1007/s40273-016-0445-5

Ramaekers, Bram L. T. ; Riemsma, Rob ; Tomini, Florian ; van Asselt, Thea ; Deshpande, Sohan ; Duffy, Steven ; Armstrong, Nigel ; Severens, Johan L. ; Kleijnen, Jos ; Joore, Manuela A. / Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer : An Evidence Review Group Perspective of an NICE Single Technology Appraisal. In: Pharmacoeconomics. 2017 ; Vol. 35, No. 2. pp. 191-202.

@article{0061397db34342a58428b803185c3bdf,

title = "Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal",

keywords = "PLACEBO-CONTROLLED PHASE-3, SURVIVAL ANALYSIS, DOUBLE-BLIND",

author = "Ramaekers, {Bram L. T.} and Rob Riemsma and Florian Tomini and {van Asselt}, Thea and Sohan Deshpande and Steven Duffy and Nigel Armstrong and Severens, {Johan L.} and Jos Kleijnen and Joore, {Manuela A.}",

year = "2017",

month = feb,

doi = "10.1007/s40273-016-0445-5",

language = "English",

volume = "35",

pages = "191--202",

journal = "Pharmacoeconomics",

issn = "1170-7690",

publisher = "Adis International Ltd",

number = "2",

}

Ramaekers, BLT, Riemsma, R, Tomini, F, van Asselt, T, Deshpande, S, Duffy, S, Armstrong, N, Severens, JL, Kleijnen, J & Joore, MA 2017, 'Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal', Pharmacoeconomics, vol. 35, no. 2, pp. 191-202. https://doi.org/10.1007/s40273-016-0445-5

Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer : An Evidence Review Group Perspective of an NICE Single Technology Appraisal. / Ramaekers, Bram L. T.; Riemsma, Rob; Tomini, Florian; van Asselt, Thea; Deshpande, Sohan; Duffy, Steven; Armstrong, Nigel; Severens, Johan L.; Kleijnen, Jos ; Joore, Manuela A.

In: Pharmacoeconomics, Vol. 35, No. 2, 02.2017, p. 191-202.

Research output: Contribution to journal › Review article › peer-review

TY - JOUR

T1 - Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer

T2 - An Evidence Review Group Perspective of an NICE Single Technology Appraisal

AU - Ramaekers, Bram L. T.

AU - Riemsma, Rob

AU - Tomini, Florian

AU - van Asselt, Thea

AU - Deshpande, Sohan

AU - Duffy, Steven

AU - Armstrong, Nigel

AU - Severens, Johan L.

AU - Kleijnen, Jos

AU - Joore, Manuela A.

PY - 2017/2

Y1 - 2017/2

KW - PLACEBO-CONTROLLED PHASE-3

KW - SURVIVAL ANALYSIS

KW - DOUBLE-BLIND

U2 - 10.1007/s40273-016-0445-5

DO - 10.1007/s40273-016-0445-5

M3 - Review article

C2 - 27566699

VL - 35

SP - 191

EP - 202

JO - Pharmacoeconomics

JF - Pharmacoeconomics

SN - 1170-7690

IS - 2

ER -